Microbot Medical Stock Operating Margin

MBOT Stock

USD 3.12 0.23 7.96%

Microbot Medical's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Microbot Stock price.

		Last Reported	Projected for Next Year
	Operating Profit Margin	(360.92)	(342.88)

Build AI portfolio with Microbot Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Microbot Medical Company Operating Margin Analysis

Microbot Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Current Microbot Medical Operating Margin

-342.88

Most of Microbot Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Microbot Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Microbot Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Microbot Medical is extremely important. It helps to project a fair market value of Microbot Stock properly, considering its historical fundamentals such as Operating Margin. Since Microbot Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Microbot Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Microbot Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Short Term Investments	Common Stock	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Property Plant Equipment	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.66	-0.74	-0.6	0.06	0.07	0.71	0.98	0.57	0.01	0.38	-0.38	0.41	0.54	0.65	0.49	0.43	0.61	0.61	0.63	-0.39
Total Stockholder Equity	0.66		-0.93	0.17	-0.12	-0.06	-0.07	0.78	-0.06	0.36	-0.21	0.05	0.9	-0.18	-0.02	0.02	-0.05	0.15	0.88	0.88	-0.09
Net Debt	-0.74	-0.93		-0.04	-0.01	0.1	-0.11	-0.83	-0.14	-0.16	0.05	-0.08	-0.78	-0.03	-0.11	-0.1	-0.05	-0.26	-0.84	-0.84	0.24
Retained Earnings	-0.6	0.17	-0.04		-0.08	-0.13	-0.95	-0.44	-0.66	0.31	-0.8	0.65	0.36	-0.79	-0.88	-0.66	-0.64	-0.63	0.11	0.08	0.34
Accounts Payable	0.06	-0.12	-0.01	-0.08		0.04	0.19	0.04	0.14	-0.17	0.08	-0.06	-0.29	0.25	0.28	0.21	0.23	0.11	-0.09	-0.09	-0.3
Net Receivables	0.07	-0.06	0.1	-0.13	0.04		0.15	0.05	0.22	0.16	-0.02	-0.37	-0.01	0.1	0.07	-0.02	0.08	0.13	-0.21	-0.22	0.35
Total Liab	0.71	-0.07	-0.11	-0.95	0.19	0.15		0.56	0.82	-0.32	0.7	-0.55	-0.31	0.88	0.87	0.63	0.62	0.67	-0.03	0.0	-0.43
Total Current Assets	0.98	0.78	-0.83	-0.44	0.04	0.05	0.56		0.49	0.06	0.2	-0.26	0.56	0.43	0.5	0.33	0.3	0.49	0.73	0.74	-0.32
Short Term Debt	0.57	-0.06	-0.14	-0.66	0.14	0.22	0.82	0.49		-0.33	0.35	-0.44	-0.26	0.91	0.63	0.25	0.37	0.52	-0.03	-0.01	-0.29
Short Term Investments	0.01	0.36	-0.16	0.31	-0.17	0.16	-0.32	0.06	-0.33		-0.39	-0.1	0.27	-0.59	-0.13	-0.05	-0.41	0.32	0.02	0.01	0.09
Common Stock	0.38	-0.21	0.05	-0.8	0.08	-0.02	0.7	0.2	0.35	-0.39		-0.53	-0.39	0.52	0.74	0.66	0.56	0.54	-0.09	-0.06	-0.35
Current Deferred Revenue	-0.38	0.05	-0.08	0.65	-0.06	-0.37	-0.55	-0.26	-0.44	-0.1	-0.53		0.23	-0.45	-0.74	-0.57	-0.57	-0.62	0.17	0.16	-0.01
Net Tangible Assets	0.41	0.9	-0.78	0.36	-0.29	-0.01	-0.31	0.56	-0.26	0.27	-0.39	0.23		-0.35	-0.34	-0.25	-0.18	-0.22	0.83	0.81	0.22
Long Term Debt Total	0.54	-0.18	-0.03	-0.79	0.25	0.1	0.88	0.43	0.91	-0.59	0.52	-0.45	-0.35		0.73	0.43	0.61	0.43	-0.04	-0.02	-0.34
Capital Surpluse	0.65	-0.02	-0.11	-0.88	0.28	0.07	0.87	0.5	0.63	-0.13	0.74	-0.74	-0.34	0.73		0.82	0.68	0.82	-0.04	0.0	-0.48
Deferred Long Term Liab	0.49	0.02	-0.1	-0.66	0.21	-0.02	0.63	0.33	0.25	-0.05	0.66	-0.57	-0.25	0.43	0.82		0.83	0.7	-0.06	-0.03	-0.49
Property Plant Equipment	0.43	-0.05	-0.05	-0.64	0.23	0.08	0.62	0.3	0.37	-0.41	0.56	-0.57	-0.18	0.61	0.68	0.83		0.37	-0.06	-0.03	-0.26
Short Long Term Debt	0.61	0.15	-0.26	-0.63	0.11	0.13	0.67	0.49	0.52	0.32	0.54	-0.62	-0.22	0.43	0.82	0.7	0.37		-0.06	-0.02	-0.48
Net Invested Capital	0.61	0.88	-0.84	0.11	-0.09	-0.21	-0.03	0.73	-0.03	0.02	-0.09	0.17	0.83	-0.04	-0.04	-0.06	-0.06	-0.06		1.0	-0.15
Net Working Capital	0.63	0.88	-0.84	0.08	-0.09	-0.22	0.0	0.74	-0.01	0.01	-0.06	0.16	0.81	-0.02	0.0	-0.03	-0.03	-0.02	1.0		-0.18
Capital Stock	-0.39	-0.09	0.24	0.34	-0.3	0.35	-0.43	-0.32	-0.29	0.09	-0.35	-0.01	0.22	-0.34	-0.48	-0.49	-0.26	-0.48	-0.15	-0.18

Click cells to compare fundamentals

A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

Competition

Predict Microbot Medical

Operating Profit Margin Over Time

Microbot Pretax Profit Margin

Pretax Profit Margin

(340.02)

At this time, Microbot Medical's Pretax Profit Margin is comparatively stable compared to the past year.

Microbot Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbot Medical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microbot Medical could also be used in its relative valuation, which is a method of valuing Microbot Medical by comparing valuation metrics of similar companies.

Microbot Medical is currently under evaluation in operating margin category among its peers.

Microbot Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Microbot Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Microbot Medical's managers, analysts, and investors.

Environmental

Governance

Social

Microbot Fundamentals

	Return On Equity	-0.66
	Return On Asset	-0.4
	Current Valuation	108.08 M
	Shares Outstanding	44.34 M
	Shares Owned By Institutions	8.29 %
	Number Of Shares Shorted	8.14 M
	Price To Earning	(3.42) X
	Price To Book	4.78 X
	EBITDA	(11.35 M)
	Net Income	(11.44 M)
	Cash And Equivalents	9.29 M
	Cash Per Share	1.31 X
	Total Debt	111 K
	Debt To Equity	0.07 %
	Current Ratio	5.60 X
	Book Value Per Share	0.83 X
	Cash Flow From Operations	(8.83 M)
	Short Ratio	4.12 X
	Earnings Per Share	(0.64) X
	Target Price	9.0
	Number Of Employees	20
	Beta	1.16
	Market Capitalization	138.33 M
	Total Asset	6.03 M
	Retained Earnings	(90.94 M)
	Working Capital	3.36 M
	Current Asset	15.21 M
	Current Liabilities	9.83 M
	Net Asset	6.03 M

About Microbot Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Microbot Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbot Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbot Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC